Summit Therapeutics Inc

NASDAQ:SMMT  
5.19
-0.24 (-4.42%)
Earnings Announcements

Summit Therapeutics Reports Financial Results For The Third Quarter

Published: 11/15/2021 14:39 GMT
Summit Therapeutics Inc (SMMT) - Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2021.
Summit Therapeutics Inc - Qtrly Loss per Share $0.20.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.28

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.28

More details on our Analysts Page.